Sign In
Buy PRGO
$9.49
-0.110 (-1.15%)
At Close: Jun 23, 2026
Perrigo (PRGO) Lags on Q3 Earnings & Sales, Lowers '22 EPS View
12:47pm, Tuesday, 08'th Nov 2022
Perrigo (PRGO) reports dismal third-quarter 2022 results. Unfavorable currency movements force management to lower earnings outlook for 2022.
Perrigo Company plc (PRGO) Q3 2022 Earnings Call Transcript
12:47pm, Tuesday, 08'th Nov 2022
Perrigo Company plc (NYSE:PRGO ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Brad Joseph - Vice President, Investor Relations Murray Kessler - President, Chief Ex
Perrigo stock slides premarket after earnings miss as strong dollar and labor shortages weigh
06:44am, Tuesday, 08'th Nov 2022
Perrigo Co. PLC stock PRGO, +0.05% slid 3.8% in premarket trade Tuesday, after the maker of self-care products and OTC wellness products posted weaker-than-expected third-quarter earnings and said the
Perrigo to Release Third Quarter 2022 Financial Results on November 8, 2022
05:20pm, Tuesday, 25'th Oct 2022
DUBLIN , Oct. 25, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its third quarter 2022 financial result
Perrigo Company plc Is Back On Track
11:19am, Thursday, 20'th Oct 2022
Uncertain outlook prompts stock market investors to seek protection. US-listed stocks of loyal dividend payers with robust activity also serve as effective hedging tools against market headwinds.
FDA Panel to Review Perrigo's (PRGO) OTC Birth Control Pill
12:47pm, Tuesday, 13'th Sep 2022
The FDA schedules a joint advisory committee meeting in November 2022 to review Perrigo's (PRGO) regulatory filing for the first-ever over-the-counter birth control pill.
Perrigo (PRGO) Down 8.2% Since Last Earnings Report: Can It Rebound?
12:47pm, Thursday, 08'th Sep 2022
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Perrigo's (PRGO) Q2 Earnings Misses by a Cent, Sales Beat
01:32pm, Tuesday, 09'th Aug 2022
Perrigo (PRGO) delivers mixed second-quarter 2022 results. Higher demand for cough/cold products continues during the reported quarter.
Perrigo (PRGO) CEO, Murray Kessler on Q2 2022 Results - Earnings Call Transcript
12:12pm, Tuesday, 09'th Aug 2022
Perrigo Company Plc (NYSE:PRGO ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Murray Kessler - President, Chief Executive Officer Eduardo Bezerra - Executive Vice Pr
Perrigo (PRGO) Lags Q2 Earnings Estimates
09:02am, Tuesday, 09'th Aug 2022
Perrigo (PRGO) delivered earnings and revenue surprises of -2.27% and 5.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PERRIGO TO RELEASE SECOND QUARTER 2022 FINANCIAL RESULTS ON AUGUST 9, 2022
08:13am, Wednesday, 27'th Jul 2022
DUBLIN , July 27, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its second quarter 2022 financial resu
Perrigo: HRA Acquisition To Drive Significant Growth
06:27am, Wednesday, 20'th Jul 2022
The acquisition of HRA Pharma to drive significant revenue and earnings growth for Perrigo in the coming quarters. PRGO is facing contracted gross margins due to inflationary headwinds.
Perrigo (PRGO) Unit Files for OTC Birth Control Pill With FDA
01:06pm, Tuesday, 12'th Jul 2022
The FDA's potential approval of Perrigo (PRGO) unit, HRA Pharma's OTC birth control pills can make the drug the first of its kind to be made available without prescription in the United States.
FDA Might Authorize First Over-the-Counter Birth Control Pill
07:35pm, Monday, 11'th Jul 2022
A company is asking the FDA to make its progestin-only pill available without prescription.
FDA to review first ever over-the-counter birth control pill
01:52pm, Monday, 11'th Jul 2022
The application from the Paris-based HRA Pharma comes on the back of the U.S. Supreme Court's decision in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide
